Saudi Pharmaceutical Journal Journal

Overview
Identity
View All

publication venue for

Vedolizumab does not increase risk of clostridium difficile infection in patients with inflammatory bowel disease using vedolizumab: A retrospective cohort study. 31:101736-101736. 2023
Topical nitroglycerin in newborns with ischemic injuries: A systematic review. 29:764-774. 2021

has subject area

1115 Pharmacology and Pharmaceutical Sciences (FoR)
Pharmacology & Pharmacy (Science Metrix)